Zoetis slightly topped analyst estimates for profitability and met those for revenue in its fourth quarter. But as investors ...
BTIG lowered the firm’s price target on Zoetis (ZTS) to $200 from $225 and keeps a Buy rating on the shares. The company delivered an in-line ...
Zoetis received a USDA conditional license for its H5N2 avian flu vaccine for chickens, marking a step in addressing the ...
We recently published a list of the 10 Best Drug Stocks to Buy Now. In this article, we are going to take a look at where ...
In a report released today, Michael Ryskin from Bank of America Securities maintained a Buy rating on Zoetis (ZTS – Research Report). The ...
Zoetis Inc. (NYSE:ZTS) today announced that a representative from the company will participate in the following investor ...
Investment analysts at William Blair reduced their Q1 2025 EPS estimates for shares of Zoetis in a note issued to investors ...
Thousands of U.S. health agency employees were terminated and told it was for poor performance, though they'd received strong ...